Evidence map›Paper›PMID 35822247›Full record

ArticleCell proliferation2022

Dental pulp stem cells-based therapy for the oviduct injury via immunomodulation and angiogenesis in vivo.

Lihua Luo, Zhenjie Xing, Xiangyan Liao, Yejian Li, Yu Luo, Yilong Ai, Yan He, Qingsong Ye

Open access · goldAbstract read
In one paragraph

Article in Cell proliferation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lihua LuoSchool and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.ORCID https://orcid.org/0000-0002-3017-5165
Zhenjie XingSchool and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.ORCID https://orcid.org/0000-0001-9770-3105
Xiangyan LiaoSchool and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
Yejian LiSchool and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
Yu LuoCenter of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Yilong AiFoshan Stomatological Hospital, School of Medicine, Foshan University, Foshan, China.
Yan HeTianyou Hospital, Wuhan University of Science and Technology, Wuhan, China.
Qingsong YeSchool and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.ORCID https://orcid.org/0000-0002-2868-9247
Wenzhou Medical University · CNFoshan University · CNWuhan University · CNWuhan University of Science and Technology · CN

Funding

National Natural Science Funding of China 81871503Wenzhou Major Scientific and Technological Innovation Key Medical and Health Project ZY2019010Zhejiang Province Program of the Medical and Health Science and Technology 2022KY218Zhejiang Provincial Natural Science Foundation of China LGF21H140007
6 · The paper itself

Abstract

objectivesAs a result of the current limitation of therapeutic strategies, the repair and regeneration of oviduct injuries required an alternative treatment. We present a novel approach to treat oviduct injuries through a dental pulp stem cells (DPSCs)-based therapy. MATERIALS AND

methodsIn vitro and in vivo models have been established. Immunofluorescence staining, flow cytometry and enzyme-linked immunosorbent assay (ELISA) analysis were used to investigate the features and angiogenic properties of DPSCs, as well as their impact on macrophages, in vitro. For the in vivo experiment with female SD rat model, immunohistochemical staining and ELISA analysis were used to assess the effects of DPSCs on the repair and regeneration of damaged oviducts.

resultsThe present data showed that intraperitoneal injection of DPSCs reduced the expression of IL-6 and TNF-α to inhibit the immunoreaction in injured sites, as well as increased the expression of VEGF to promote the in situ formation of vessel-like structures, thus the repair and recovery process could be initiated.

conclusionsWe concluded that DPSCs-based therapy could be a novel potential technique for restoring the structure and function of damaged oviduct by enhancing immuno-regulated effect and promoting angiogenic property.

Indexed as

Stem CellsVascular Endothelial Growth Factor AAnimalsCell DifferentiationCell ProliferationCells, CulturedDental PulpFemaleHumansImmunomodulationInterleukin-6OviductsRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaInterleukin-6Tumor Necrosis Factor-alphaVascular Endothelial Growth Factor A

Identifiers

PMID35822247
PMCPMC9528759
OpenAlexW4285395992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.